Recursion Pharmaceuticals has reported updated data from its ELUCIDATE & TUPELO trials, but the stock has failed to mount a ...

Q4 2025 Earnings Call January 22, 2026 5:00 PM ESTCompany ParticipantsJohn Pitzer - Corporate Vice President of Corporate ...

Microsoft programs appear to be suffering an outage.

Explore how real estate tokenization works through smart contract architecture, enabling secure, transparent property ...

Tuesday, January 20, 2026 The Zacks Research Daily presents the best research output of our analyst team. Today's Research ...

I should have been more careful before I clicked and opened the invitation on my computer. It was from my friend Adrienne, ...

The Mila artificial intelligence institute in Quebec is raising a US$100-million venture capital fund with plans to invest in ...

A small number of cancer cells with the ability to change their identities and behaviors appear to be a key driver of cancer progression and its ability to evolve resistance to treatment, Memorial ...

A new study by researchers in Japan offers new insights into how protocells may have inherited and enriched genetic material before modern biology emerged. By exposing mixed phospholipid vesicles to ...

Modern cells are complex chemical entities with cytoskeletons, finely regulated internal and external molecules, and genetic material that determines ...

Last week, two of the biggest and oldest companies in the burgeoning AI drug discovery space announced a surprise merger. In a roughly 75-25 deal, Recursion Bio and Exscientia will (if the merger goes ...

Looking for a research and development job? Check out the BioSpace list of 12 companies hiring life sciences professionals like you.